Preview: ADMA Biologics's Earnings
Portfolio Pulse from Benzinga Insights
ADMA Biologics is set to release its latest quarterly earnings report on August 9, 2023. Analysts estimate an earnings per share (EPS) of -$0.02. The company's past performance shows a trend of beating EPS estimates, which has led to increases in share price. The stock is currently trading at $4.14 and has seen a 94.58% increase over the last 52-week period.
August 08, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ADMA Biologics is expected to report an EPS of -$0.02. The company has a history of beating EPS estimates, which has positively impacted its share price. The stock has increased by 94.58% over the last 52 weeks.
ADMA Biologics has a history of beating EPS estimates, which has led to increases in its share price. Given this trend and the positive performance of the stock over the last 52 weeks, it is likely that the upcoming earnings report will have a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100